michigan semaglutide intestinal paralysis lawsuit While many patients are seeing life-changing results with GLP-1 medications, doctors say the medications can also come with risks if they are not dosed properly. (Photo: AP Photo/David J. Phillip, File) michigan glp-1 intestinal paralysis lawsuit

For most patients receiving medication from one place, this wont be an issue

How GLP-1 Receptor Agonists Work for Weight Management Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management but increasingly recognised for their significant weight management properties

In February 2021, the researchers published findings from the STEP 1 trial in The New England Journal of Medicine showing that patients who injected semaglutide lost close to 15% of their body weight, on average, compared with 2.4% among patients receiving the placebo

The injection itself is a quick, easy process

You should pay attention to any mental health changes, especially sudden changes in your mood, behaviors, thoughts, or feelings